
Search
Filter Results
Displaying 531–540 of 1063 results
-
Apr 12, 2021
Encouraging Early Report for Three Patients in LCA1-GUCY2D Gene Therapy Clinical Trial
Development of the emerging gene therapy is being funded by the Foundation’s RD Fund
-
Apr 9, 2021
Foundation Invests $5.5 Million in Seven New Translational Research Projects
Projects target a variety of conditions including: age-related macular degeneration, Stargardt disease, retinitis pigmentosa, and Usher syndrome type 3A
-
Mar 30, 2021
Bionic Sight’s Optogenetic Therapy Enables Blind Patients to Detect Light and Motion in Early Trial
The approach holds potential for restoring vision to people with little or no vision
-
Mar 24, 2021
ProQR’s RNA Therapy for USH2A Performs Well in Phase 1/2 Clinical Trial
The company is planning two Phase 2/3 clinical trials for the treatment
-
Mar 23, 2021
Foundation Fighting Blindness Launches Chapter Program Rebrand
The program honors Lulie Gund and her legacy and commitment to the Foundation’s Chapter community.
-
Mar 22, 2021
18-year-old Marty Dubecky has a very unique decision to make. There are currently four gene therapy clinical trials for him to choose from to enroll in, which would have been unheard of 15 years ago when he was first diagnosed with XLRP.
-
A Chapter is the collective group of volunteers and leaders coming together to fulfill the mission of the Foundation Fighting Blindness. They do this by hosting Chapter meetings. Each meeting will provide educational updates, provide resources in the community, and identify, cultivate, and generate revenue.
-
Join your local chapter to help drive the Foundation Fighting Blindness mission. Our chapters regularly hold meetings that will provide educational updates, provide resources in the community, and identify, cultivate, and fundraise.
-
Lulie's Next Chapter for Light & Vision
Our vision is to recruit and retain a high performing and well-structured community-based grassroots Chapter leadership and membership. This focus will center around education, resources, and revenue throughout the community.
-
Mar 16, 2021
Foundation’s No-Cost Program Increased Genetic Testing Rates for IRD Patients
More than 8,000 people have applied for genetic testing through the Foundation’s program